These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 31211666)

  • 1. Added Value of Comprehensive Program to Provide Universal Access to Care for Sputum Smear-Negative Drug-Resistant Tuberculosis, China.
    Huang F; van den Hof S; Qu Y; Li Y; Zhang H; Wang L; Sun M; Lu W; Hou S; Zhang T; Huan S; Chin DP; Cobelens F
    Emerg Infect Dis; 2019 Jul; 25(7):1289-1296. PubMed ID: 31211666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of tuberculosis, multidrug resistant tuberculosis and associated risk factors among smear negative presumptive pulmonary tuberculosis patients in Addis Ababa, Ethiopia.
    Sinshaw W; Kebede A; Bitew A; Tesfaye E; Tadesse M; Mehamed Z; Yenew B; Amare M; Dagne B; Diriba G; Alemu A; Getahun M; Fikadu D; Desta K; Tola HH
    BMC Infect Dis; 2019 Jul; 19(1):641. PubMed ID: 31324227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of genotype MTBDRplus VER 2.0 line probe assay for the detection of MDR-TB in smear positive and negative sputum samples.
    Meaza A; Kebede A; Yaregal Z; Dagne Z; Moga S; Yenew B; Diriba G; Molalign H; Tadesse M; Adisse D; Getahun M; Desta K
    BMC Infect Dis; 2017 Apr; 17(1):280. PubMed ID: 28415989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid detection of extensively drug-resistant (XDR-TB) strains from multidrug-resistant tuberculosis (MDR-TB) cases isolated from smear-negative pulmonary samples in an Intermediate Reference Laboratory in India.
    Vashistha H; Hanif M; Saini S; Khanna A; Sharma S; Sidiq Z; Ahmed V; Dubey M; Chopra KK; Shrivastava D
    Indian J Tuberc; 2016 Jul; 63(3):144-148. PubMed ID: 27865234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Xpert MTB/RIF Ultra performance for pulmonary tuberculosis diagnosis on smear-negative respiratory samples in a French centre.
    Hodille E; Maisson A; Charlet L; Bauduin C; Genestet C; Fredenucci I; Rasigade JP; Lina G; Dumitrescu O
    Eur J Clin Microbiol Infect Dis; 2019 Mar; 38(3):601-605. PubMed ID: 30680567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct application of the INNO-LiPA Rif.TB line-probe assay for rapid identification of Mycobacterium tuberculosis complex strains and detection of rifampin resistance in 360 smear-positive respiratory specimens from an area of high incidence of multidrug-resistant tuberculosis.
    Viveiros M; Leandro C; Rodrigues L; Almeida J; Bettencourt R; Couto I; Carrilho L; Diogo J; Fonseca A; Lito L; Lopes J; Pacheco T; Pessanha M; Quirim J; Sancho L; Salfinger M; Amaral L
    J Clin Microbiol; 2005 Sep; 43(9):4880-4. PubMed ID: 16145166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Line probe assay for detection of
    Desikan P; Panwalkar N; Mirza SB; Chaturvedi A; Ansari K; Varathe R; Chourey M; Kumar P; Pandey M
    Indian J Med Res; 2017 Jan; 145(1):70-73. PubMed ID: 28574017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic Accuracy and Utility of FluoroType MTBDR, a New Molecular Assay for Multidrug-Resistant Tuberculosis.
    de Vos M; Derendinger B; Dolby T; Simpson J; van Helden PD; Rice JE; Wangh LJ; Theron G; Warren RM
    J Clin Microbiol; 2018 Sep; 56(9):. PubMed ID: 29976588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early detection of multidrug- and pre-extensively drug-resistant tuberculosis from smear-positive sputum by direct sequencing.
    Chen J; Peng P; Du Y; Ren Y; Chen L; Rao Y; Wang W
    BMC Infect Dis; 2017 Apr; 17(1):300. PubMed ID: 28438132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic performance of genoType
    Idrees F; Irfan M; Jabeen K; Farooqi J; Hasan R
    Int J Mycobacteriol; 2017; 6(2):122-126. PubMed ID: 28559511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A simple and economical in-house phage technique for the rapid detection of rifampin, isoniazid, ethambutol, streptomycin, and ciprofloxacin drug resistance in Mycobacterium tuberculosis, directly on decontaminated sputum samples.
    Hemvani N; Patidar V; Chitnis DS
    Int J Infect Dis; 2012 May; 16(5):e332-6. PubMed ID: 22369736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prevalence and risk factors on the resistance related to second-line drugs among multi-drug resistant tuberculosis cases in Shanghai, China].
    Li J; Zhang YY; Gui XH; Yuan ZA; Pan QC; Mei J; Shen X
    Zhonghua Liu Xing Bing Xue Za Zhi; 2012 Aug; 33(8):796-8. PubMed ID: 22967331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performance of the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis and rifampin resistance in a low-incidence, high-resource setting.
    Rice JP; Seifert M; Moser KS; Rodwell TC
    PLoS One; 2017; 12(10):e0186139. PubMed ID: 29016684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic performance of automated liquid culture and molecular line probe assay in smear-negative pulmonary tuberculosis.
    Kotwal A; Biswas D; Raghuvanshi S; Sindhwani G; Kakati B; Sharma S
    Trop Doct; 2017 Apr; 47(2):118-123. PubMed ID: 27784827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implementation of the INNO-LiPA Rif. TB® line-probe assay in rapid detection of multidrug-resistant tuberculosis in Latvia.
    Skenders GK; Holtz TH; Riekstina V; Leimane V
    Int J Tuberc Lung Dis; 2011 Nov; 15(11):1546-52, i. PubMed ID: 22008771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid detection of Mycobacterium tuberculosis and rifampicin resistance in extrapulmonary tuberculosis and sputum smear-negative pulmonary suspects using Xpert MTB/RIF.
    Ullah I; Javaid A; Masud H; Ali M; Basit A; Ahmad W; Younis F; Yasmin R; Khan A; Jabbar A; Husain M; Butt ZA
    J Med Microbiol; 2017 Apr; 66(4):412-418. PubMed ID: 28425873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis in a high HIV prevalence setting.
    Theron G; Peter J; van Zyl-Smit R; Mishra H; Streicher E; Murray S; Dawson R; Whitelaw A; Hoelscher M; Sharma S; Pai M; Warren R; Dheda K
    Am J Respir Crit Care Med; 2011 Jul; 184(1):132-40. PubMed ID: 21493734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance of Biochip system in detecting drug resistant and multidrug-resistant tuberculosis using sputum collected from multiple clinical settings in Zhejiang, China.
    Xu K; Wang S; Wu J; Liu Z; Ji Z; Zheng L; Jin X; Ren J; Yang S; Li Z; Yuan J; Zhao Y; Li L
    Sci Rep; 2018 Jul; 8(1):10587. PubMed ID: 30002508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transmission of Mycobacterium tuberculosis in China: a population-based molecular epidemiologic study.
    Yang C; Shen X; Peng Y; Lan R; Zhao Y; Long B; Luo T; Sun G; Li X; Qiao K; Gui X; Wu J; Xu J; Li F; Li D; Liu F; Shen M; Hong J; Mei J; DeRiemer K; Gao Q
    Clin Infect Dis; 2015 Jul; 61(2):219-27. PubMed ID: 25829000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Converging risk factors but no association between HIV infection and multidrug-resistant tuberculosis in Kazakhstan.
    van den Hof S; Tursynbayeva A; Abildaev T; Adenov M; Pak S; Bekembayeva G; Ismailov S
    Int J Tuberc Lung Dis; 2013 Apr; 17(4):526-31. PubMed ID: 23485387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.